Skip to Content

S Z 229 (Zolpidem tartrate extended release 12.5 mg)

Pill imprint S Z 229 has been identified as Zolpidem tartrate extended release 12.5 mg.

Zolpidem is used in the treatment of insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 12.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Zolpidem tartrate extended release 12.5 mg S Z 229
Zolpidem tartrate extended release
Imprint:
S Z
229
Strength:
12.5 mg
Color:
Pink
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous anxiolytics, sedatives and hypnotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Sandoz Inc
National Drug Code (NDC):
00781-5316
Inactive Ingredients:
silicon dioxide
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
ferric oxide red
magnesium silicate
titanium dioxide

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide